Rafael Holdings, Inc. (NYSE:RFL) Sees Significant Decline in Short Interest

Rafael Holdings, Inc. (NYSE:RFL) was the recipient of a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 40,257 shares, a drop of 44.7% from the November 30th total of 72,743 shares. Based on an average daily trading volume, of 210,772 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.1% of the shares of the company are short sold. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 210,772 shares, the days-to-cover ratio is presently 0.2 days.

Rafael Stock Up 0.8%

NYSE RFL traded up $0.01 during trading hours on Friday, reaching $1.19. The company’s stock had a trading volume of 87,762 shares, compared to its average volume of 175,069. Rafael has a 1 year low of $1.15 and a 1 year high of $3.19. The company has a market capitalization of $61.61 million, a price-to-earnings ratio of -1.40 and a beta of 0.69. The firm’s 50-day moving average price is $1.29 and its 200-day moving average price is $1.53.

Rafael (NYSE:RFL) last released its quarterly earnings data on Wednesday, October 29th. The company reported ($0.28) earnings per share (EPS) for the quarter. Rafael had a negative net margin of 3,044.70% and a negative return on equity of 32.82%. The company had revenue of $0.89 million for the quarter.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on RFL. Wall Street Zen downgraded Rafael from a “hold” rating to a “sell” rating in a research note on Friday, September 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Rafael in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Rafael presently has an average rating of “Sell”.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Simplex Trading LLC purchased a new position in shares of Rafael during the second quarter valued at about $32,000. Marshall Wace LLP bought a new position in Rafael during the second quarter valued at approximately $50,000. Americana Partners LLC bought a new position in Rafael during the second quarter valued at approximately $76,000. Citadel Advisors LLC grew its holdings in Rafael by 132.3% during the 3rd quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock valued at $99,000 after buying an additional 41,335 shares in the last quarter. Finally, Cable Car Capital LP bought a new stake in Rafael in the 2nd quarter worth approximately $173,000. Institutional investors own 11.30% of the company’s stock.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.